GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Debt-to-Revenue

Abbott India (BOM:500488) Debt-to-Revenue : 0.01 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Abbott India's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹465 Mil. Abbott India's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹368 Mil. Abbott India's annualized Revenue for the quarter that ended in Mar. 2024 was ₹57,545 Mil. Abbott India's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.01.


Abbott India Debt-to-Revenue Historical Data

The historical data trend for Abbott India's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Debt-to-Revenue Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.04 0.03 0.02 0.01

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - 0.02 - 0.01

Competitive Comparison of Abbott India's Debt-to-Revenue

For the Drug Manufacturers - General subindustry, Abbott India's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Abbott India's Debt-to-Revenue falls into.



Abbott India Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Abbott India's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(464.7 + 367.6) / 58489.1
=0.01

Abbott India's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(464.7 + 367.6) / 57545.2
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Abbott India Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Abbott India's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines